Published in Respir Med on December 20, 2007
Chronic Obstructive Pulmonary Disease Biomarker Study | NCT02050022
Effect of high flow oxygen on mortality in chronic obstructive pulmonary disease patients in prehospital setting: randomised controlled trial. BMJ (2010) 3.30
Prevention of acute exacerbations of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest (2015) 2.32
Impact of exacerbations on health care cost and resource utilization in chronic obstructive pulmonary disease patients with chronic bronchitis from a predominantly Medicare population. Int J Chron Obstruct Pulmon Dis (2012) 1.47
Direct costs of chronic obstructive pulmonary disease among managed care patients. Int J Chron Obstruct Pulmon Dis (2010) 1.40
Harms of overoxygenation in patients with exacerbation of chronic obstructive pulmonary disease. CMAJ (2017) 1.38
Association between lung function and exacerbation frequency in patients with COPD. Int J Chron Obstruct Pulmon Dis (2010) 1.35
Optimizing pulmonary rehabilitation in chronic obstructive pulmonary disease--practical issues: a Canadian Thoracic Society Clinical Practice Guideline. Can Respir J (2010) 1.10
Implementation of a targeted screening program to detect airflow obstruction suggestive of chronic obstructive pulmonary disease within a presurgical screening clinic. Can Respir J (2015) 1.09
Variations in the management of acute exacerbations of chronic obstructive pulmonary disease. Can Respir J (2013) 0.96
Exercise prescription for hospitalized people with chronic obstructive pulmonary disease and comorbidities: a synthesis of systematic reviews. Int J Chron Obstruct Pulmon Dis (2012) 0.92
Executive summary: prevention of acute exacerbation of COPD: American College of Chest Physicians and Canadian Thoracic Society Guideline. Chest (2015) 0.91
Clinical predictors of frequent exacerbations in subjects with severe chronic obstructive pulmonary disease (COPD). Respir Med (2010) 0.89
Safe and effective prescription of exercise in acute exacerbations of chronic obstructive pulmonary disease: rationale and methods for an integrated knowledge translation study. Can Respir J (2013) 0.86
Chronic obstructive pulmonary disease exacerbation frequency and severity. Int J Chron Obstruct Pulmon Dis (2013) 0.84
Comparison of clinico-physiologic and CT imaging risk factors for COPD exacerbation. J Korean Med Sci (2011) 0.84
The burden of illness in patients with moderate to severe chronic obstructive pulmonary disease in Canada. Can Respir J (2012) 0.82
Clinical, humanistic, and economic burden of chronic obstructive pulmonary disease (COPD) in Canada: a systematic review. BMC Res Notes (2015) 0.82
A Retrospective Longitudinal Within-Subject Risk Interval Analysis of Immunoglobulin Treatment for Recurrent Acute Exacerbation of Chronic Obstructive Pulmonary Disease. PLoS One (2015) 0.81
Optimal oxygen titration in patients with chronic obstructive pulmonary disease: a role for automated oxygen delivery? Can Respir J (2013) 0.79
Study of Patients' Willingness to Pay for a Cure of Chronic Obstructive Pulmonary Disease in Taiwan. Int J Environ Res Public Health (2016) 0.79
Palliative care for chronic illness: driving change. CMAJ (2016) 0.78
Cost-effectiveness of interventions for chronic obstructive pulmonary disease (COPD) using an Ontario policy model. Ont Health Technol Assess Ser (2012) 0.78
Integrated interdisciplinary care for patients with chronic obstructive pulmonary disease reduces emergency department visits, admissions and costs: a quality assurance study. Can Respir J (2013) 0.77
Impact of individualized care on readmissions after a hospitalization for acute exacerbation of COPD. Int J Chron Obstruct Pulmon Dis (2016) 0.75
Cost Analysis of Hospitalized Patients with Chronic Obstructive Pulmonary Disease: A State-Level Cross-Sectional Study. Tanaffos (2016) 0.75
Effects of a Community-Based, Post-Rehabilitation Exercise Program in COPD: Protocol for a Randomized Controlled Trial With Embedded Process Evaluation. JMIR Res Protoc (2016) 0.75
Effects of clinical pathways for chronic obstructive pulmonary disease (COPD) on patient, professional and systems outcomes: protocol for a systematic review. Syst Rev (2016) 0.75
Identifying Distinct Healthcare Pathways During Episodes of Chronic Obstructive Pulmonary Disease Exacerbations. Medicine (Baltimore) (2016) 0.75
Pulmonary Rehabilitation in Ontario: A Cross-Sectional Survey. Ont Health Technol Assess Ser (2015) 0.75
COPD a social disease: inappropriateness and pharmaco-economics. The role of the specialist: present and future. Multidiscip Respir Med (2010) 0.75
Predicting Healthcare Utilization by Patients Admitted for COPD Exacerbation. J Clin Diagn Res (2016) 0.75
Pulmonary rehabilitation coupled with negative pressure ventilation decreases decline in lung function, hospitalizations, and medical cost in COPD: A 5-year study. Medicine (Baltimore) (2016) 0.75
Non-pharmacological management of chronic obstructive pulmonary disease. Ulster Med J (2015) 0.75
COPD exacerbation care bundle improves standard of care, length of stay, and readmission rates. Int J Chron Obstruct Pulmon Dis (2016) 0.75
The Association Between Rate and Severity of Exacerbations in Chronic Obstructive Pulmonary Disease: An Application of a Joint Frailty-Logistic Model. Am J Epidemiol (2016) 0.75
Cost-effectiveness of tiotropium versus glycopyrronium in moderate to very severe chronic obstructive pulmonary disease in Canada, Spain, Sweden, and the UK. Clinicoecon Outcomes Res (2016) 0.75
Impact of a COPD comprehensive case management program on hospital length of stay and readmission rates. Int J Chron Obstruct Pulmon Dis (2017) 0.75
Expanding Paramedicine in the Community (EPIC): study protocol for a randomized controlled trial. Trials (2014) 0.75
A longitudinal, retrospective cohort study on the impact of roflumilast on exacerbations and economic burden among chronic obstructive pulmonary disease patients in the real world. Int J Chron Obstruct Pulmon Dis (2015) 0.75
The Burden of Illness Related to Chronic Obstructive Pulmonary Disease Exacerbations in Québec, Canada. Can Respir J (2017) 0.75
Readability and Suitability of COPD Consumer Information. Can Respir J (2017) 0.75
Spreading improvements for advanced COPD care through a Canadian Collaborative. Int J Chron Obstruct Pulmon Dis (2017) 0.75
Risk factors for near-fatal asthma. A case-control study in hospitalized patients with asthma. Am J Respir Crit Care Med (1998) 2.15
Adenosine deaminase in the diagnosis of tuberculous pleural effusions. A report of 218 patients and review of the literature. Chest (1991) 1.78
Laparoscopic diagnosis of ascites in Lesotho. Br Med J (Clin Res Ed) (1985) 1.68
The effect of adding ipratropium bromide to salbutamol in the treatment of acute asthma: a pooled analysis of three trials. Chest (1998) 1.63
Cost-effectiveness of dabigatran etexilate for the prevention of stroke and systemic embolism in atrial fibrillation: a Canadian payer perspective. Thromb Haemost (2011) 1.59
Is the delay in diagnosis of pulmonary tuberculosis related to exposure to fluoroquinolones or any antibiotic? Int J Tuberc Lung Dis (2011) 1.58
Evaluation of the protected brush catheter and bronchoalveolar lavage in the diagnosis of nosocomial pneumonia. J Intensive Care Med (1993) 1.49
The GINA Asthma Challenge: reducing asthma hospitalisations. Eur Respir J (2011) 1.45
Geographic trends in incidence of hip fractures: a comprehensive literature review. Osteoporos Int (2011) 1.44
The assessment and management of patients with acute asthma. Int J Tuberc Lung Dis (2006) 1.44
Longitudinal progression of sporadic Parkinson's disease: a multi-tracer positron emission tomography study. Brain (2009) 1.40
beta2-Adrenergic receptor haplotypes in mild, moderate and fatal/near fatal asthma. Am J Respir Crit Care Med (1998) 1.40
Cost-effectiveness of a new interferon-based blood assay, QuantiFERON-TB Gold, in screening tuberculosis contacts. Int J Tuberc Lung Dis (2008) 1.38
Adverse drug reactions associated with first-line anti-tuberculosis drug regimens. Int J Tuberc Lung Dis (2007) 1.28
Polymorphisms in the IL4, IL4RA, and FCERIB genes and asthma severity. J Allergy Clin Immunol (2000) 1.25
A randomized trial comparing peak expiratory flow and symptom self-management plans for patients with asthma attending a primary care clinic. Am J Respir Crit Care Med (1998) 1.16
Human bladder carcinoma cell lines as indicators of oncogenic change relevant to urothelial neoplastic progression. Br J Cancer (1995) 1.09
Cost effectiveness of therapy with combinations of long acting bronchodilators and inhaled steroids for treatment of COPD. Thorax (2008) 1.08
An estimate of the future size of the tuberculosis problem in sub-Saharan Africa resulting from HIV infection. Tuber Lung Dis (1992) 1.08
The impact of obstructive sleep apnea and daytime sleepiness on work limitation. Sleep Med (2007) 1.03
Budesonide/formoterol maintenance and reliever therapy: impact on airway inflammation in asthma. Eur Respir J (2008) 1.03
Pulmonary actinomycosis complicating infliximab therapy for Crohn's disease. Thorax (2007) 1.01
Prevalence of tumor necrosis factor-alpha and angiotensin converting enzyme polymorphisms in mild/moderate and fatal/near-fatal asthma. Am J Respir Crit Care Med (1999) 0.97
The location of constitutional neurofibromatosis 2 (NF2) splice site mutations is associated with the severity of NF2. J Med Genet (2005) 0.90
A systematic review of risk factors associated with near-fatal and fatal asthma. Can Respir J (2005) 0.89
Risk of upper gastrointestinal bleeding with oral bisphosphonates and non steroidal anti-inflammatory drugs: a case-control study. Aliment Pharmacol Ther (2009) 0.89
Evaluation of incidental renal and adrenal masses. Am Fam Physician (2001) 0.88
Tuberculous peritonitis in Lesotho. Tubercle (1986) 0.88
Growth of the L-cell in galactose medium. J Cell Physiol (1967) 0.88
Genetic variation in carboxylesterase genes and susceptibility to isoniazid-induced hepatotoxicity. Pharmacogenomics J (2010) 0.87
Impact of adverse drug reaction and predictivity of quality of life status in tuberculosis. Eur Respir J (2010) 0.85
Incorrect positioning of nasogastric feeding tubes and the development of pneumothorax. Can Assoc Radiol J (1992) 0.84
Genotype-phenotype correlations for cataracts in neurofibromatosis 2. J Med Genet (2003) 0.84
Massive haemolysis in a group A recipient of a group O peripheral blood stem cell allogeneic transplant. Transfus Med (2001) 0.83
Excess mortality associated with second hip fracture. Osteoporos Int (2015) 0.81
Changes in first hip fracture rates in British Columbia Canada, 1990-2004. Osteoporos Int (2011) 0.80
Rash rates with egfr inhibitors: meta-analysis. Curr Oncol (2011) 0.80
The utility of ambulatory pH monitoring in patients presenting with chronic cough and asthma. Can J Gastroenterol (2007) 0.79
The role of the C-C chemokine receptor-5 Delta32 polymorphism in asthma and in the production of regulated on activation, normal T cells expressed and secreted. J Allergy Clin Immunol (2001) 0.79
A mathematical model for the prediction of the impact of HIV infection on tuberculosis. Int J Epidemiol (1994) 0.79
Ciprofloxacin-induced delirium. Ann Pharmacother (1997) 0.79
The role of calcium channel blockers in the treatment of essential hypertension. Arch Intern Med (1991) 0.78
Development of PCR-SSOP for the identification of HLA-A*02 subtypes and determination of HLA-A*02 frequencies within different ethnic populations. Tissue Antigens (1997) 0.78
A systematic review of the psychological risk factors associated with near fatal asthma or fatal asthma. Respiration (2006) 0.77
Autobiographical memory across the life-span. J Gerontol (1984) 0.76
Management of acute asthma. CMAJ (1989) 0.75
Recommendations regarding mechanical ventilation in acute asthma. Ann Allergy (1989) 0.75
Circadian rhythm in the brain serotonin concentrations of the lizard, Anolis carolinensis. Comp Biochem Physiol C (1975) 0.75
Person-perception in adulthood: a categories analysis. Int J Aging Hum Dev (1984) 0.75
Actual and perceived sex and generational differences in interpersonal style: structural and quantitative issues. J Gerontol (1978) 0.75
BCG vaccination and the prevalence of latent tuberculosis infection in an aboriginal population. Int J Tuberc Lung Dis (2006) 0.75
Patient education, self management plans and peak flow measurement. Respir Med (1992) 0.75
Learning and development: mutual bases in a dialectical perspective. Hum Dev (1980) 0.75
Transfusion in paroxysmal nocturnal haemoglobinuria: a change of policy. Transfus Med (1994) 0.75
Spinning your wheels? Tips on establishing a chapter research committee. Focus Crit Care (1987) 0.75
Rapid fluorimetric determination of phenothiazines employing in situ photochemical oxidation. Anal Chem (1976) 0.75
The use of the electronic (computer) cross-match. Vox Sang (2013) 0.75
Laparoscopy in the diagnosis of peritoneal tuberculosis. J Infect Dis (1989) 0.75
Inhibition of ovine gastric acid secretion by intraduodenal long-chain fatty acids. Am J Physiol (1982) 0.75
Airway hyperresponsiveness and asthma. Agents Actions Suppl (1989) 0.75
Continuous determination of ascorbic acid by photobleaching of methylene blue. Anal Chem (1972) 0.75
How Do People Think About Intelligence? Multivariate Behav Res (1988) 0.75
Standards for burn nursing practice. J Burn Care Rehabil (1989) 0.75
Pithomycotoxicosis (facial eczema) in ruminants in the Azores, Portugal. Vet Rec (2005) 0.75